Vecihi Batuman

Title: The Innovations of Vecihi Batuman

Introduction

Vecihi Batuman is a notable inventor based in New Orleans, LA (US). He has made significant contributions to the field of medicine, particularly in the treatment of kidney injuries caused by iodinated radiocontrast media. His innovative approach has the potential to improve patient outcomes in clinical settings.

Latest Patents

Vecihi Batuman holds a patent for the "Use of pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP analogs for treating contrast-induced nephropathy." This patent outlines methods and compositions aimed at treating, managing, preventing, or reducing kidney injury in mammals, including humans, caused by iodinated radiocontrast media. The methods involve administering effective amounts of PACAP-like compounds, which include native human PACAP38, native human PACAP27, and native human vasoactive intestinal peptide (VIP), along with their agonists, analogs, fragments, and derivatives. The patent also provides pharmaceutical compositions that can be used in conjunction with other therapeutic agents to protect the kidneys during medical procedures.

Career Highlights

Vecihi Batuman is associated with the Administrators of the Tulane Educational Fund, where he continues to advance his research and innovations. His work focuses on developing effective treatments for contrast-induced nephropathy, a condition that can arise during medical imaging procedures.

Collaborations

Vecihi has collaborated with notable colleagues such as Jerome L Maderdrut and Min Li. Their combined expertise contributes to the ongoing research and development of effective therapeutic strategies in the field of nephrology.

Conclusion

Vecihi Batuman's contributions to medical science, particularly through his patent on PACAP and its analogs, highlight his commitment to improving healthcare outcomes. His work exemplifies the impact of innovative thinking in addressing critical medical challenges.